First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage
Introduction: We report a case of the use of nebulized TXA and first line pembrolizumab with chemotherapy for treatment of Stage III gestational trophoblastic neoplasia (GTN) in the setting of hemodynamic instability secondary to pulmonary hemorrhage. Case review: The patient is a 44 year old G3P2 w...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Gynecologic Oncology Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578925000852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850209314186199040 |
|---|---|
| author | Rose Emlein Heather Einstein Amy Brown Amanda Ramos Jonathan A. Cosin Clare Zhou Marguerite Palisoul |
| author_facet | Rose Emlein Heather Einstein Amy Brown Amanda Ramos Jonathan A. Cosin Clare Zhou Marguerite Palisoul |
| author_sort | Rose Emlein |
| collection | DOAJ |
| description | Introduction: We report a case of the use of nebulized TXA and first line pembrolizumab with chemotherapy for treatment of Stage III gestational trophoblastic neoplasia (GTN) in the setting of hemodynamic instability secondary to pulmonary hemorrhage. Case review: The patient is a 44 year old G3P2 with newly diagnosed Stage III intermediate trophoblastic tumor (epithelial trophoblastic tumor and placental site trophoblastic tumor) with known pulmonary metastases. She was admitted for anemia secondary to hemoptysis requiring blood transfusion and expedition of chemotherapy. She received induction etoposide & cisplatin (EP) and was initiated on nebulized tranexamic acid. After two cycles of induction chemotherapy with continued increase in β-hcg levels she was started on pembrolizumab in addition to first-line multi agent chemotherapy with etoposide, methotrexate, actinomycin-D (EMA)-EP. She received six cycles of EMA/EP with pembrolizumab, requiring various dose reductions and delays. β-hcg reached a maximum of 72,316 on cycle 1 day 1 of EMA/EP and normalized after cycle 3. She completed 12 months of maintenance pembrolizumab. Β-hcg has remained undetectable and she has recovered to her pre-diagnosis level of functioning. Conclusion: GTN can be highly vascular and pulmonary metastases can cause life-threatening hemorrhage. Nebulized TXA provides a promising method to stabilize pulmonary hemorrhage in GTN. Pembrolizumab has been previously shown to be effective in recurrent or chemo-resistant GTN. Use in combination with first line therapy in GTN provides a promising option for patients with highly morbid disease, requiring aggressive therapy. |
| format | Article |
| id | doaj-art-270f3a91a34c4ad79dc7dc7e0417e7c9 |
| institution | OA Journals |
| issn | 2352-5789 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Gynecologic Oncology Reports |
| spelling | doaj-art-270f3a91a34c4ad79dc7dc7e0417e7c92025-08-20T02:10:02ZengElsevierGynecologic Oncology Reports2352-57892025-06-015910176010.1016/j.gore.2025.101760First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhageRose Emlein0Heather Einstein1Amy Brown2Amanda Ramos3Jonathan A. Cosin4Clare Zhou5Marguerite Palisoul6Department of Obstetrics and Gynecology Residency Program, University of Connecticut, USA; Corresponding author at: 972 West Boulevard, Hartford, CT 06105, USA.Division of Gynecology Oncology, Hartford Healthcare, USADivision of Gynecology Oncology, Hartford Healthcare, USADivision of Gynecology Oncology, Hartford Healthcare, USADivision of Gynecology Oncology, Hartford Healthcare, USADivision of Gynecology Oncology, Hartford Healthcare, USADivision of Gynecology Oncology, Hartford Healthcare, USAIntroduction: We report a case of the use of nebulized TXA and first line pembrolizumab with chemotherapy for treatment of Stage III gestational trophoblastic neoplasia (GTN) in the setting of hemodynamic instability secondary to pulmonary hemorrhage. Case review: The patient is a 44 year old G3P2 with newly diagnosed Stage III intermediate trophoblastic tumor (epithelial trophoblastic tumor and placental site trophoblastic tumor) with known pulmonary metastases. She was admitted for anemia secondary to hemoptysis requiring blood transfusion and expedition of chemotherapy. She received induction etoposide & cisplatin (EP) and was initiated on nebulized tranexamic acid. After two cycles of induction chemotherapy with continued increase in β-hcg levels she was started on pembrolizumab in addition to first-line multi agent chemotherapy with etoposide, methotrexate, actinomycin-D (EMA)-EP. She received six cycles of EMA/EP with pembrolizumab, requiring various dose reductions and delays. β-hcg reached a maximum of 72,316 on cycle 1 day 1 of EMA/EP and normalized after cycle 3. She completed 12 months of maintenance pembrolizumab. Β-hcg has remained undetectable and she has recovered to her pre-diagnosis level of functioning. Conclusion: GTN can be highly vascular and pulmonary metastases can cause life-threatening hemorrhage. Nebulized TXA provides a promising method to stabilize pulmonary hemorrhage in GTN. Pembrolizumab has been previously shown to be effective in recurrent or chemo-resistant GTN. Use in combination with first line therapy in GTN provides a promising option for patients with highly morbid disease, requiring aggressive therapy.http://www.sciencedirect.com/science/article/pii/S2352578925000852 |
| spellingShingle | Rose Emlein Heather Einstein Amy Brown Amanda Ramos Jonathan A. Cosin Clare Zhou Marguerite Palisoul First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage Gynecologic Oncology Reports |
| title | First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage |
| title_full | First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage |
| title_fullStr | First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage |
| title_full_unstemmed | First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage |
| title_short | First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage |
| title_sort | first line pembrolizumab used concurrently with multi agent chemotherapy and inhaled tranexamic acid txa for management of stage iii mixed trophoblastic tumor complicated by pulmonary hemorrhage |
| url | http://www.sciencedirect.com/science/article/pii/S2352578925000852 |
| work_keys_str_mv | AT roseemlein firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage AT heathereinstein firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage AT amybrown firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage AT amandaramos firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage AT jonathanacosin firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage AT clarezhou firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage AT margueritepalisoul firstlinepembrolizumabusedconcurrentlywithmultiagentchemotherapyandinhaledtranexamicacidtxaformanagementofstageiiimixedtrophoblastictumorcomplicatedbypulmonaryhemorrhage |